RE:Questioning The Deal - Part 1I have been asked in the last few days why a pharma, perhaps one of Bioasis's current partners, hasn't come forward and offer more than this terrible deal offers.
Never thought I'd say it, but now, I'd welcome a CVR deal from decent pharma (Chiesi or J&J). Even just 10 cents US up front with milestones down the road would be an easy YES vote for me. At least they would know what to do with XB3.